NCT04692714

Brief Summary

Total knee replacement surgery (TKA) is a treatment for advanced tibial-femoral osteoarthritis. This intervention is justified in case of significant discomfort and failure of medical treatment. It aims to replace the native internal and external femoro-tibial joints with a joint between a femoral implant and a tibial implant. Implants can be cemented or cementless. The longevity of these implants depends among other things on the quality of the bone fixation of the implants. It is therefore essential that this fixation be evaluated. The advantages of an uncemented TKA are the preservation of bone stock, the absence of wear by cement debris and prolonged fixation thanks to osseointegration. These characteristics are all the more interesting in a young population. Numerous studies have been carried out on the survival of TKA with and without cement. The results found are not unanimous and mainly concern the survival of the implants and the presence of radiological signs of loosening. In addition, no study has evaluated the results of TKA with or without cement implanted using robotic assistance. The precision provided by the robotic system could improve the results of these uncemented implants. Very few studies are interested in the functional results according to the cementation or not of TKA. And most of these studies do not have a high level of methodological evidence. We would like to prospectively evaluate the functional results, survival, as well as the rate of radiological border after TKA with or without cement posed with robotic assistance, in the short and medium term.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
30mo left

Started May 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress62%
May 2022Oct 2028

First Submitted

Initial submission to the registry

December 30, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 5, 2021

Completed
1.4 years until next milestone

Study Start

First participant enrolled

May 16, 2022

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 16, 2025

Completed
3.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 16, 2028

Expected
Last Updated

December 3, 2024

Status Verified

November 1, 2024

Enrollment Period

3 years

First QC Date

December 30, 2020

Last Update Submit

November 28, 2024

Conditions

Keywords

total knee arthroplastyprosthesiscementMAKOIKS score

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in International Knee Society (IKS) function score at 12 Months

    The knee function will be evaluated using the delta of the IKS function score between baseline (before surgery) and 1 year after total knee arthroplasty, and compared between the 2 arms.

    Baseline and 12 months

Secondary Outcomes (7)

  • Change from baseline in IKS objective score at 12 Months

    Baseline and 12 months

  • Change from baseline in IKS function score at 60 Months

    Baseline and 60 months

  • Change from baseline in IKS objective score at 60 Months

    Baseline and 60 months

  • Forgotten joint score at 12 Months

    12 months

  • Forgotten joint score at 60 Months

    60 months

  • +2 more secondary outcomes

Study Arms (2)

Experimental knee prosthesis implantation

EXPERIMENTAL

Patients included in this arm will have a total knee arthroplasty using a Triathlon prosthesis by STRYKER implemented without additional cement using the MAKO robot

Device: Knee prosthesis implementation without additional cement

Conventional knee prosthesis implantation

ACTIVE COMPARATOR

Patients included in this arm will have a total knee arthroplasty using a Triathlon prosthesis by STRYKER implemented with additional cement using the MAKO robot

Device: Knee prosthesis implementation with additional cement

Interventions

During surgery, a TRIATHLON prosthesis will be implemented with the MAKO robot with additional cement.

Conventional knee prosthesis implantation

During surgery, a TRIATHLON prosthesis will be implemented with the MAKO robot without additional cement.

Experimental knee prosthesis implantation

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of internal, external or global femorotibial knee osteoarthritis
  • Indication for first-line total knee arthroplasty
  • having given informed consent
  • Affiliated with a social security scheme
  • Patient being able to understand the objectives of the study and willing to comply with postoperative instructions.

You may not qualify if:

  • Patient with rheumatoid arthritis
  • Preoperative flexion less than 90 °
  • Prosthesis associated with an osteotomy
  • History of surgery on the operated knee, except arthroscopy
  • Poor bone quality assessed by the surgeon
  • Knee deformation greater than 10 ° preoperatively (HKA)
  • Pregnant or breastfeeding Women
  • Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care, persons admitted to a health or social institution for purposes other than research
  • Adults subject to a legal protection measure
  • Patient already participating to another clinical trial that might jeopardize the current trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of orthopedic surgery, Hopital Nord Croix-Rousse- Hospices Civils de Lyon

Lyon, 69004, France

RECRUITING

Chirurgie Orthopédique et Traumatologique Centre Hospitalier Lyon Sud, Hospices Civils de Lyon

Lyon, 69495, France

RECRUITING

Related Links

Study Officials

  • Sébastien LUSTIG, Professor

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 30, 2020

First Posted

January 5, 2021

Study Start

May 16, 2022

Primary Completion

May 16, 2025

Study Completion (Estimated)

October 16, 2028

Last Updated

December 3, 2024

Record last verified: 2024-11

Locations